Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

April 30, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

PHX1149T

200 mg

DRUG

PHX1149T

400 mg

DRUG

Placebo

Placebo

Trial Locations (62)

Unknown

Norwalk

Orange

Santa Ana

Daytona Beach

Kissimmee

Atlanta

Honolulu

Brockton

St Louis

Cincinnati

El Paso

San Antonio

Norfolk

Caba

La Plata

Lanús

Paraná

Salta

Rosario

Corrientes

Hyderabad

Bangalore

Kalaburagi

Mumbai

Nagpur

Nashik

Navi Mumbai

Pune

Chennai

Kelantan

Kuala Lumpur

Perak

Sarawak

Arequipa

Chiclayo-Lambayeque

Lima Cercado

Lince

San Miguel

San Isisdro

Manila

Quezon City

San Juan City

Cebu City

Brasov

Jud. Brasov

Sector 1

Sector 2

Galati

Ploieşti

Sibiu

Ratchatavi

Muang

Simferopol

Ivano-Frankivsk

Kharkiv

2A Postysheva Pr.

Kiev

Kyiv

Lviv

Poltava

Vinnytsa

Zaporizhzhia

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Phenomix

INDUSTRY

NCT00690638 - Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter